Although MoCA is primarily designed as a cognitive screening tool, it is still relatively time consuming (taking approx. Recent evidence has demonstrated that the MoCA is, at the present moment, the best screening tool for MCI (pooled sensitivity, 89% pooled specificity, 75%) 2, and that it is also an excellent screening tool for post-stroke cognitive impairment (pooled sensitivity, 81% pooled specificity, 79%) 3. in 1996, and was initially used and validated to detect mild cognitive impairment (MCI) and mild forms of Alzheimer’s disease 1. The Montreal Cognitive Assessment (MoCA) was developed by Nasreddine et al. The Chinese version of the MoCA 5-min protocol can be used as a valid screening for patients with stroke. These three assessments demonstrated equal performance in differentiating patients with stroke from controls. We found that the 5-min protocol did not differ from the MoCA in differentiating patients with cognitive impairments from those without (area under the receiver operating characteristic curve, AUC, of 0.948 for the MoCA 5-min protocol v.s. In this study, the Neurobehavioural Cognitive Status Examination (NCSE) was used as an external criterion of cognitive impairment. A total of 54 patients and 27 healthy controls were enrolled in this study. The aim of the present study was to examine the concurrent validity of 2 Chinese versions of the short version of the Montreal Cognitive Assessment (MoCA) in patients with stroke, i.e., MoCA 5-minute protocol and National Institute for Neurological Disorders and Stroke and Canadian Stroke Network (NINDS-CSN) 5-minute Protocol.

Moca test score of 1